Through 2024, advancements in AI and predictive analytics rapidly revolutionized the Medical Instruments industry, driving innovation in diagnostics, patient monitoring and personalized treatment.

Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...

For adults with type 1 diabetes, a regimen of inhaled Technosphere insulin (TI) plus insulin degludec is noninferior t ...

This year’s top diabetes content focused on pediatric metabolic health, misconceptions about weight loss drugs, and more.

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty impressive.

If you are a CGM user who recently shifted from your previous glucose meter ... Most smartwatches and other wearable devices ...

Abbott and Dexcom are two leaders in the continuous glucose monitoring (CGM) space. They offer market-leading platforms, with ...

TNDM announced that the in-warranty users of the t:slim X2 insulin pump in Canada can now access full compatibility with both Dexcom’s DXCM G7 and G6 Continuous Glucose Monitoring (“CGM”) systems ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

The devices, worn as small circular sticker, provide detailed information on blood sugar levels after eating food via a small ...

The data is sent to smartphones and can be shared with physicians or data centers. For people with diabetes, continuous ...